Novartis AG (NVS)
144.55
+0.21
(+0.15%)
USD |
NYSE |
Jan 20, 11:20
Novartis Free Cash Flow: 17.15B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Roche Holding AG | 14.17B |
| Amgen, Inc. | 11.54B |
| AstraZeneca PLC | 9.870B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Avidity Biosciences, Inc. | -592.26M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 6.574B |
| Cash from Investing (Quarterly) | -858.23M |
| Cash from Financing (Quarterly) | -2.754B |
| Free Cash Flow Per Share (Quarterly) | 2.961 |
| Free Cash Flow to Equity (Quarterly) | 6.359B |
| Free Cash Flow to Firm (Quarterly) | 6.007B |
| Free Cash Flow Yield | 6.02% |